Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Wirth

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Translational Oncology|January 25, 2022
Targeting the translational machinery to overcome apoptosis resistance in pancreatic cancerMatthias Wirth
Methods in Molecular Biology (Clifton, N.J.)|October 21, 2016
Engineering of Conditional Class I Hdac Knockout Mice and Generation of a Time-Spatial Knockout by a Dual Recombination SystemSieglinde Bayer, Matthias Wirth
Trends in Cancer|July 26, 2017
MYC: A Stratification Marker for Pancreatic Cancer TherapyMatthias Wirth, Günter Schneider
Cancer Research|June 4, 2024
A Hypoxia-Epigenetics Axis Drives EMT in Pancreatic CancerMatthias Wirth, Günter Schneider
Molecular Informatics|July 29, 2016
Bioactive Molecules: Perfectly Shaped for Their Target?Matthias Wirth, Wolfgang H B Sauer
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
CRISPR Activation/Interference Screen to Identify Genetic Networks in HDAC-Inhibitor-Resistant CellsPaul Jung, Laura Schmalbrock, Matthias Wirth
Signal Transduction and Targeted Therapy|August 31, 2023
Boosting T cell immunity against cytomegalovirus: a potential strategy combating human aging and age-related diseasesMatthias Wirth, Walburgis Brenner, Oliver H Krämer
EJNMMI Research|October 12, 2021
Rationale for MYC imaging and targeting in pancreatic cancerGünter Schneider, Matthias Wirth, Ulrich Keller, et al.
Cancers|December 17, 2020
Ubiquitination and Ubiquitin-Like Modifications in Multiple Myeloma: Biology and TherapyMatthias Wirth, Markus Schick, Ulrich Keller, et al.
Molecular Cancer Therapeutics|July 14, 2016
Concepts to Target MYC in Pancreatic CancerMatthias Wirth, Siavosh Mahboobi, Oliver H Krämer, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Translational Oncology|January 25, 2022
Targeting the translational machinery to overcome apoptosis resistance in pancreatic cancerMatthias Wirth
Methods in Molecular Biology (Clifton, N.J.)|October 21, 2016
Engineering of Conditional Class I Hdac Knockout Mice and Generation of a Time-Spatial Knockout by a Dual Recombination SystemSieglinde Bayer, Matthias Wirth
Trends in Cancer|July 26, 2017
MYC: A Stratification Marker for Pancreatic Cancer TherapyMatthias Wirth, Günter Schneider
Cancer Research|June 4, 2024
A Hypoxia-Epigenetics Axis Drives EMT in Pancreatic CancerMatthias Wirth, Günter Schneider
Molecular Informatics|July 29, 2016
Bioactive Molecules: Perfectly Shaped for Their Target?Matthias Wirth, Wolfgang H B Sauer
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
CRISPR Activation/Interference Screen to Identify Genetic Networks in HDAC-Inhibitor-Resistant CellsPaul Jung, Laura Schmalbrock, Matthias Wirth
Signal Transduction and Targeted Therapy|August 31, 2023
Boosting T cell immunity against cytomegalovirus: a potential strategy combating human aging and age-related diseasesMatthias Wirth, Walburgis Brenner, Oliver H Krämer
EJNMMI Research|October 12, 2021
Rationale for MYC imaging and targeting in pancreatic cancerGünter Schneider, Matthias Wirth, Ulrich Keller, et al.
Cancers|December 17, 2020
Ubiquitination and Ubiquitin-Like Modifications in Multiple Myeloma: Biology and TherapyMatthias Wirth, Markus Schick, Ulrich Keller, et al.
Molecular Cancer Therapeutics|July 14, 2016
Concepts to Target MYC in Pancreatic CancerMatthias Wirth, Siavosh Mahboobi, Oliver H Krämer, et al.
Pageof 7